Skip to content
Abierto

Solicitation

Illumina MiSeq i100 System

75F40126Q22123

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

Awarded

Illumina, Inc.

$53,442.90 obligated so far on USAspending

Description

As published on SAM.gov.

This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government’s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
KMW3CRWNAAF3
CAGE
1WCS2
Vendor location
San Diego, CA
Contract
75F40126P00095, purchase order
Obligated
$53,442.90
Actions
1 between June 25, 2026 and June 25, 2026
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
This Acquisition Provides One (1) Whole Genome Sequencing Instrument, Including Training and a ONE-YEAR Manufacturer'S Warranty, to Support Microbiological Testing Requirements
Match
solicitation number 75F40126Q22123 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 15, 2026

    Solicitation

    Due May 22, 2026 at 10:30 AM EDT. SAM.gov, notice 8af5d39c0b3244db8bdaf54c057a3bf8

Points of contact